mgh_logo

Harvard-Medical-School-logo

Generic filters

risk for major congenital malformation

Still Not Enough Data on the Reproductive Safety of Oxcarbazepine (Trileptal)

This meta-analysis is reassuring regarding risk for malformations in children exposed prenatally to oxcarbazepine; however, we still need more data to fully assess reproductive safety.

By |2025-06-26T09:07:24-04:00January 2nd, 2023|Anti-Epileptic Drugs, Outcomes, Pregnancy & Medications, Risk of Malformations|Comments Off on Still Not Enough Data on the Reproductive Safety of Oxcarbazepine (Trileptal)
Read More

Antiepileptic Drugs and Pregnancy: The Good,The Bad, and The Ugly

EURAP is an international registry for antiepileptic drugs and pregnancy.  At its inception in 1999, it included only European countries but EURAP has grown and now includes 42 countries from Europe, Australia, Asia, South America. [...]

By |2025-06-26T09:07:47-04:00May 1st, 2018|Anti-Epileptic Drugs, Outcomes, Pregnancy & Medications, Risk of Malformations|Comments Off on Antiepileptic Drugs and Pregnancy: The Good,The Bad, and The Ugly
Read More
Copyright 2026 MGH Center for Women's Mental Health | All Rights Reserved
Go to Top